An Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive Regimens

NCT01183247 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Comparative Study
Immunosuppressive Agents

Interventions

DRUG: Rapamycin
DRUG: Everolimus
DRUG: Prednisone

Sponsor

University Hospital, Basel, Switzerland

Collaborators

[object Object]